Fox Chase Cancer Center News

PHILADELPHIA (October 30, 2023) — Henkel Valentine, PhD, a postdoctoral fellow in the lab of Philip Abbosh, MD, PhD, in the Nuclear Dynamics and Cancer Research Program at Fox Chase Cancer Center, was one of six postdoctoral researchers nationwide recently recognized as an IMPACT Fellow by the National Postdoctoral Association.

PHILADELPHIA (October 30, 2023) — A majority of clinicians with expertise in hereditary gastroenterology support implementing genetic screening known as universal germline testing for the diagnosis of colorectal cancer, according to the results of a clinical practice survey conducted by Sanjeevani Arora, PhD, an Assistant Professor in the Cancer Prevention and Control Research Program at Fox Chase Cancer Center.

PHILADELPHIA (October 26, 2023) — Lucia Borriello, PhD, an Assistant Professor in the Department of Cancer and Cellular Biology at the Lewis Katz School of Medicine at Temple University and a member of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, has been awarded a $100,000 Mary Kay Ash Foundation Innovative/Translational Cancer Research Grant.

PHILADELPHIA (October 25, 2023) — Nosayaba Enofe, MD, a fellow in the Advanced Minimally Invasive Thoracic Surgical Oncology Fellowship at Fox Chase Cancer Center, discussed his experience with a unique minimally invasive hybrid approach to esophagectomy at the American College of Surgeons Clinical Congress.

PHILADELPHIA (October 20, 2023) — Rebecca Shulman, MD, Assistant Professor in the Department of Radiation Oncology at Fox Chase Cancer Center, was recently recognized with the Robert A. Winn Diversity in Clinical Trials Career Development Award.

PHILADELPHIA (October 19, 2023) — The African-Caribbean Cancer Consortium (AC3), which was formed in 2006 to further the study of viral, genetic, environmental, and lifestyle risk factors for cancer in populations of African descent, held its 8th annual conference recently in Mombasa, Kenya. Several researchers were recognized for their work and dedication to the AC3’s mission.

PHILADELPHIA (October 18, 2023) — Igor Astsaturov, MD, PhD, Associate Professor in the Department of Hematology/Oncology and co-director of The Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, has been appointed inaugural holder of the Paul F. Engstrom Professorship in Oncology.

PHILADELPHIA (October 17, 2023) — As the first initiative of an emerging collaboration, Fox Chase Cancer Center has invested in Nucleus RadioPharma, a company specializing in the development and distribution of radiopharmaceuticals, targeted therapies that deliver radiation directly to cancer cells. The company’s technology platform is considered to be at the forefront of radiopharmaceutical research and designed to advance new therapies from clinical trials to commercialization. Fox Chase and Nucleus also have signed a Letter of Intent to potentially enable to a deeper collaboration, including partnership in developing a radiopharmaceutical manufacturing site and clinical trials involving radiopharmaceuticals.